Fig. 14
From: Next-generation nanomaterials: advancing ocular anti-inflammatory drug therapy
Reproduced from Ref. [347] with permission from John Wiley and Sons
Ocular pathologies induced by the improper utilization of nanomaterials. The image showcases irritation and toxic responses elicited by nanomaterials interacting with the eye surface (cornea, conjunctiva), intraocular structures (e.g., iris, ciliary body, choroid, and lens), or various regions of the retina, macula, and optic nerve.